Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Sell
44
PSX Quote, Financials, Valuation and Earnings
Last price:
$125.54
Seasonality move
:
7.08%
Day range:
$124.79 - $129.05
52-week range:
$108.91 - $174.08
Dividend yield:
3.67%
P/E ratio:
25.40x
P/S ratio:
0.37x
P/B ratio:
1.87x
Volume:
4.6M
Avg. volume:
4.1M
1-year change:
-21.12%
Market cap:
$51.2B
Revenue:
$143.2B
EPS (TTM):
$4.94
Analysts' Opinion
-
Consensus RatingPhillips 66 has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $139.29, Phillips 66 has an estimated upside of 10.99% from its current price of $125.49.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $124.43 representing 100% downside risk from its current price of $125.49.
Fair Value
-
According to the consensus of 15 analysts, Phillips 66 has 10.99% upside to fair value with a price target of $139.29 per share.
PSX vs. S&P 500
-
Over the past 5 trading days, Phillips 66 has underperformed the S&P 500 by -1.48% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Phillips 66 does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Phillips 66 revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Phillips 66 reported revenues of $33.7B.
Earnings Growth
-
Phillips 66 earnings have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Phillips 66 reported earnings per share of $0.01.
Enterprise value:
70.5B
EV / Invested capital:
1.45x
Price / LTM sales:
0.37x
EV / EBIT:
19.48x
EV / Revenue:
0.49x
PEG ratio (5yr expected):
--
EV / Free cash flow:
30.25x
Price / Operating cash flow:
22.71x
Enterprise value / EBITDA:
11.79x
Gross Profit (TTM):
$10.8B
Return On Assets:
2.82%
Net Income Margin (TTM):
1.48%
Return On Equity:
7%
Return On Invested Capital:
4.22%
Operating Margin:
-0.13%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $170B | $147.4B | $143.2B | $38.3B | $33.7B | |
| Gross Profit | $18.4B | $17.3B | $10.8B | $3.9B | $2.1B | |
| Operating Income | $9.6B | $8B | $1.7B | $1.5B | -$42M | |
| EBITDA | $16.9B | $12.4B | $6B | $2.5B | $1B | |
| Diluted EPS | $22.95 | $15.47 | $4.94 | $2.86 | $0.01 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $13.3B | $14.7B | $21.9B | $19.9B | $17.9B | |
| Total Assets | $54.7B | $55.6B | $76.4B | $75.5B | $72.6B | |
| Current Liabilities | $9.5B | $12.8B | $15.9B | $15.9B | $15.1B | |
| Total Liabilities | $33.2B | $34B | $42.3B | $43.9B | $44.1B | |
| Total Equity | $21.5B | $21.6B | $34.1B | $31.7B | $28.5B | |
| Total Debt | $15.9B | $14.4B | $17.2B | $19.4B | $20.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.8B | $7B | $4.2B | $2.2B | $1.2B | |
| Cash From Investing | -$1.5B | -$1.8B | -$2.5B | -$608M | -$345M | |
| Cash From Financing | -$6.4B | -$8.1B | -$3.3B | -$1.8B | -$724M | |
| Free Cash Flow | $8.9B | $4.9B | $2.3B | $1.6B | $692M | |
PSX
Sector
Market Cap
$51.2B
$62.4M
Price % of 52-Week High
72.09%
61%
Dividend Yield
3.67%
0%
Shareholder Yield
10.92%
4.69%
1-Year Price Total Return
-21.12%
-22.46%
Beta (5-Year)
1.309
1.027
Dividend yield:
3.67%
Annualized payout:
$4.50
Payout ratio:
88.9%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$126.77
200-day SMA
Sell
Level
$129.74
Bollinger Bands (100)
Buy
Level
117.44 - 130.22
Chaikin Money Flow
Buy
Level
85.3M
20-day SMA
Sell
Level
$126.14
Relative Strength Index (RSI14)
Sell
Level
49.71
ADX Line
Buy
Level
14.8
Williams %R
Neutral
Level
-34.9593
50-day SMA
Buy
Level
$123.25
MACD (12, 26)
Buy
Level
0.95
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
362.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.4099)
Buy
CA Score
(Annual)
Level (0.0179)
Buy
Beneish M-Score
(Annual)
Level (-2.3849)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.5089)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Phillips 66 is an independent refiner that owns or holds interest in 11 refineries with a total crude throughput capacity of 1.8 million barrels per day, or mmb/d, at the end of 2024. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.
Stock Forecast FAQ
In the current month, PSX has received 8 Buy ratings 7 Hold ratings, and 0 Sell ratings. The PSX average analyst price target in the past 3 months is $139.29.
-
Where Will Phillips 66 Stock Be In 1 Year?
According to analysts, the consensus estimate is that Phillips 66 share price will rise to $139.29 per share over the next 12 months.
-
What Do Analysts Say About Phillips 66?
Analysts are divided on their view about Phillips 66 share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Phillips 66 is a Sell and believe this share price will drop from its current level to $124.43.
-
What Is Phillips 66's Price Target?
The price target for Phillips 66 over the next 1-year time period is forecast to be $139.29 according to 15 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is PSX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Phillips 66 is a Buy. 8 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PSX?
You can purchase shares of Phillips 66 via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Phillips 66 shares.
-
What Is The Phillips 66 Share Price Today?
Phillips 66 was last trading at $125.54 per share. This represents the most recent stock quote for Phillips 66. Yesterday, Phillips 66 closed at $125.49 per share.
-
How To Buy Phillips 66 Stock Online?
In order to purchase Phillips 66 stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 20
Regencell Bioscience Holdings [RGC] is down 0% over the past day.
Sell
36
VMI alert for Mar 20
Valmont Industries [VMI] is down 0% over the past day.
Buy
61
ALNY alert for Mar 20
Alnylam Pharmaceuticals [ALNY] is down 0% over the past day.
